Association of hemoglobin, albumin, lymphocyte, and platelet score with risk of cerebrovascular, cardiovascular, and all-cause mortality in the general population: results from the NHANES 1999-2018
- PMID: 37424853
- PMCID: PMC10328756
- DOI: 10.3389/fendo.2023.1173399
Association of hemoglobin, albumin, lymphocyte, and platelet score with risk of cerebrovascular, cardiovascular, and all-cause mortality in the general population: results from the NHANES 1999-2018
Abstract
Background and aims: Cardiovascular and cerebrovascular disease (CCDs) contribute to leading causes of morbidity and mortality in the United States of America (USA). Hemoglobin, albumin, lymphocyte, and platelet (HALP) score, a simple and convenient indicator, could reflect the combination of inflammation and nutritional status. This study was undertaken to evaluate the associations between HALP score and risk of cardiovascular, cerebrovascular, and all-cause mortality in the general population from the National Health and Nutrition Examination Survey (NHANES) 1999-2018.
Methods: We identified 21,578 participants during the 1999-2018 cycles of the NHANES in this research. HALP score was calculated as hemoglobin (g/L) × albumin (g/L) × lymphocytes (/L)/platelets (/L). Outcomes were cerebrovascular, cardiovascular, and all-cause mortality determined by the NHANES-linked National Death Index record and followed until 31 December 2019. Survey-weighted Cox regression, restricted cubic spline analysis, and subgroup analysis were applied to investigate relationships between HALP score and risk of mortality.
Results: This cohort study comprised 49.2% male and 50.8% female, of which the median age was 47 years old. In multivariate survey-weighted Cox regression adjusting for all confounders, compared with participants with low HALP scores, participants with highest HALP score had a lower risk of all-cause mortality (adjusted HR:0.80, 95% CI: 0.73, 0.89, P < 0.0001) and cardiovascular mortality (adjusted HR:0.61, 95% CI: 0.50, 0.75, P < 0.0001), and mediate HALP score had the lowest risk of all-cause mortality (adjusted HR:0.68, 95% CI: 0.62, 0.75, P < 0.0001) and cardiovascular mortality (adjusted HR:0.60, 95% CI: 0.48, 0.75, P < 0.0001). Restricted cubic spline analysis showed a non-linear relationship between HALP score and cardiovascular and all-cause mortality (all P values <0.001).
Conclusion: HALP score was independently associated with risk of cardiovascular and all-cause mortality, but not cerebrovascular mortality.
Keywords: HALP score; NHANES; all-cause mortality; cardiovascular mortality; cerebrovascular mortality.
Copyright © 2023 Pan and Lin.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Association between hemoglobin, albumin, lymphocyte, and platelet scores and all-cause and cardiovascular mortality among adults with atherosclerotic cardiovascular disease in the United States: An analysis of NHANES.Medicine (Baltimore). 2025 May 9;104(19):e42386. doi: 10.1097/MD.0000000000042386. Medicine (Baltimore). 2025. PMID: 40355233 Free PMC article.
-
Association between hemoglobin, albumin, lymphocyte, and platelet score and all-cause and cardiovascular mortality among population with diabetes: Evidence from the NHANES 2003-2016.Diabetes Res Clin Pract. 2025 Jun;224:112212. doi: 10.1016/j.diabres.2025.112212. Epub 2025 May 7. Diabetes Res Clin Pract. 2025. PMID: 40345595
-
Association between Hemoglobin-albumin-lymphocyte-platelet score and all-cause or cardiovascular mortality in patients with diabetes or prediabetes: mediated effects of renal function.BMC Cardiovasc Disord. 2025 Apr 28;25(1):331. doi: 10.1186/s12872-025-04791-9. BMC Cardiovasc Disord. 2025. PMID: 40295902 Free PMC article.
-
What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP's prognostic ability in different cancer types.Oncotarget. 2023 Feb 25;14:153-172. doi: 10.18632/oncotarget.28367. Oncotarget. 2023. PMID: 36848404 Free PMC article. Review.
-
Prognostic significance of hemoglobin, albumin, lymphocyte and platelet score in solid tumors: a pooled study.Front Immunol. 2024 Dec 18;15:1483855. doi: 10.3389/fimmu.2024.1483855. eCollection 2024. Front Immunol. 2024. PMID: 39744624 Free PMC article.
Cited by
-
Association of Metal Exposure with Novel Immunoinflammatory Indicators.Toxics. 2024 Apr 26;12(5):316. doi: 10.3390/toxics12050316. Toxics. 2024. PMID: 38787095 Free PMC article.
-
Construction and Comparison of Multiple Serum-Based Prognostic Models for Predicting the Prognosis of Acute Exacerbations of Chronic Obstructive Pulmonary Disease.J Inflamm Res. 2024 Nov 7;17:8395-8406. doi: 10.2147/JIR.S461961. eCollection 2024. J Inflamm Res. 2024. PMID: 39534059 Free PMC article.
-
Altered albumin/neutrophil to lymphocyte ratio are associated with all-cause and cardiovascular mortality for advanced cardiovascular-kidney-metabolic syndrome.Front Nutr. 2025 Jul 16;12:1595119. doi: 10.3389/fnut.2025.1595119. eCollection 2025. Front Nutr. 2025. PMID: 40740647 Free PMC article.
-
Associations between neutrophil-percentage-to-albumin ratio level and all-cause mortality and cardiovascular disease-cause mortality in general population: evidence from NHANES 1999-2010.Front Cardiovasc Med. 2024 Sep 25;11:1393513. doi: 10.3389/fcvm.2024.1393513. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39386385 Free PMC article.
-
Inflammatory Burden Index (IBI) and Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score in Alzheimer's Disease: A Retrospective Comparative Study.Cureus. 2024 Sep 11;16(9):e69148. doi: 10.7759/cureus.69148. eCollection 2024 Sep. Cureus. 2024. PMID: 39398776 Free PMC article.
References
-
- World Health Organization . Cardiovascular diseases (Cvds) fact sheet. (2017).
-
- Theo V, Christine A, Megha A, Ryan M, Zulfiqar A, Alexandria B, et al. . Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the global burden of disease study 2015. Lancet (2016) 388(10053):1545–602. doi: 10.1016/s0140-6736(16)31678-6 - DOI - PMC - PubMed
-
- Fryar C, Chen T, Li X. Prevalence of uncontrolled risk factors for cardiovascular disease: united states, 1999-2010. NCHS Data Brief (2012) 103):1–8. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources